Steven R. Pacelli - 23 Feb 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Managing Dir., Dexcom Ventures
Signature
By: Jereme Sylvain For: Steven R Pacelli
Issuer symbol
DXCM
Transactions as of
23 Feb 2022
Transactions value $
-$98,583
Form type
4
Date filed
24 Feb 2022, 16:45
Previous filing
26 Jan 2022
Next filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$98.6K -250 -0.72% $394.33 34.4K 23 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.